Dovato (dolutegravir and lamivudine) | 合法藥品大搜索

2020年10月12日 — DOVATO film-coated tablets. (Dolutegravir/Lamivudine). 衛部藥輸字第027860 號. 本藥須由醫師處方使用. 警語：合併感染B 型肝炎病毒(HBV)與 ... Read More

2020年5月12日 — 所有感染HIV-1 的病人在開始使用DOVATO 治療之前或開始治療時，都應檢測是否. 感染B 型肝炎病毒。曾有在使用含有lamivudine 成分之抗反 ... Read More

Dovato 洛瓦梭- 產品中英文名稱、主成分和完整仿單下載。 Read More

DOVATO is a complete prescription regimen to treat HIV-1 in adults who have not received HIV-1 medicines in the past or to replace their current HIV-1 ... Read More

DOVATO is a complete prescription regimen to treat HIV-1 in adults who have not received HIV-1 medicines in the past or to replace their current HIV-1 medicines ... Read More

Dovato (dolutegravir/lamivudine) is the first complete, once daily, single-tablet, 2-drug regimen (2DR) for the treatment of HIV-1 infection in both treatment-naïve ... Read More

DOVATO (a fixed dose combination of dolutegravir and lamivudine) is indicated for the treatment of Human Immunodeficiency Virus-1 (HIV-1) infection in adults ... Read More

2019年7月11日 — 葛蘭素史克(GSK)旗下的ViiV Healthcare於7月10日表示，一項使用二合一藥物Dovato取代三合一藥物治療愛滋病的三期臨床試驗達標，顯示患者 ... Read More

If DOVATO is used in patients co-infected with HIV-1 and. HBV, additional treatment should be considered for appropriate treatment of chronic HBV; otherwise, ... Read More